Cisatracurium besylate Intravenous and Novoeight recombinant
Determining the interaction of Cisatracurium besylate Intravenous and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisatracurium besylate Intravenous-Novolin 70/30
- Cisatracurium besylate Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Cisatracurium besylate Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Cisatracurium besylate Intravenous-Novolin N
- Cisatracurium besylate Intravenous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Cisatracurium besylate Intravenous-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Cisplatin
- Novoeight recombinant-Cisplatin Intravenous
- Novoeight recombinant-Citalopram
- Novoeight recombinant-Citalopram Capsules
- Novoeight recombinant-Citalopram Hydrobromide
- Novoeight recombinant-Citalopram Oral Solution